BML Inc operates in the Medical laboratories sector.
In addition to historical fundamental analyses, the complete report available to purchase compares BML Inc with three other
pharmaceutical manufacturers in Asia:
Miraca Holdings Incorporated
sales of 181.42 billion Japanese Yen [US$1.67 billion]
of which 60%
was Clinical Examination),
Dr. Lal PathLabs Ltd
(12.03 billion Indian Rupees [US$170.16 million]
of which 100%
was Laboratories for pathological investigat), and
Falco Holdings Co Ltd
(44.16 billion Japanese Yen [US$406.68 million]
of which 62%
was Medical Test).
BML Inc reported sales of ¥117.13 billion (US$1.08 billion)
March of 2019.
increase of 3.2%
versus 2018, when the company's sales were ¥113.50 billion.
Sales at BML Inc have increased during each of the previous five years
(and since 2014, sales have increased a total of 18%).